Ophthalmoplegia/ophthalmoparesis (internal, external, or both) has been reported in dogs secondary to neoplasia affecting the oculomotor nerve and is usually given a poor prognosis. The purpose of this retrospective study was to describe the clinical findings, magnetic resonance imaging (MRI) findings, management, outcome, and follow-up in a group of canine cases with idiopathic oculomotor neuropathy. Inclusion criteria included cases with ophthalmoplegia/ophthalmoparesis (internal, external or both) as sole neuroophthalmologic signs, complete ophthalmic and neurologic examination, head MRI, and a minimum follow-up period of 1 year. Dogs with progressive neurological signs not related to oculomotor neuropathy were excluded. Fourteen cases met the inclusion criteria. All cases were unilaterally affected. Magnetic resonance imaging showed equivocal enlargement of the oculomotor nerve in three cases, mild enlargement in five, and marked enlargement in six. Contrast enhancement was present in 12 cases, being marked in six. When present, the contrast enhancement was focal in eight cases and diffuse in four. The median follow-up time was 25 months. External ophthalmoparesis improved in seven cases, five cases under no treatment and two under systemic corticosteroid therapy. The clinical signs in the other seven cases remained unchanged. Idiopathic oculomotor neuropathy should be included as a differential diagnosis in dogs presenting with unilateral ophthalmoplegia/ophthalmoparesis (internal, external, or both) with the absence of other neurologic and ophthalmic signs, and with the MRI findings restricted to the oculomotor nerve. Idiopathic oculomotor neuropathy has a good prognosis as the clinical signs do not deteriorate and they can improve without treatment. C [13] [14] [15] [16] [17] ; however, idiopathic oculomotor neuropathy is currently not reported in the veterinary literature. The aims of this study were to describe the clinical findings, magnetic resonance imaging (MRI) features, management, outcome, and long-term follow-up of canine cases diagnosed with idiopathic oculomotor neuropathy.
Introduction
T HE OCULOMOTOR NERVE (CRANIAL NERVE III OR CN III) innervates the ipsilateral extraocular muscles (dorsal, ventral, and medial rectus and ventral oblique muscle) and the ipsilateral levator palpebrae superioris muscle. 1 Additionally, CN III controls ipsilateral pupillary constriction through its parasympathetic component. 1 A complete CN III lesion (motor and parasympathetic dysfunction) causes areflexive mydriasis (internal ophthalmoplegia), a smaller palpebral fissure due to ptosis, neuromuscular dorsolateral strabismus, and the affected eye will not adduct well on testing physiological nystagmus (vestibulo-ocular reflex) (external ophthalmoparesis). 2 In the veterinary literature, canine ophthalmoplegia/ophthalmoparesis (internal, external, or both) has been reported secondary to neoplasia affecting CN III at the level of the middle cranial fossa or orbital fissure, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] and it is usually given a poor prognosis. 2 Idiopathic trigeminal and facial neuropathy have been reported in dogs [13] [14] [15] [16] [17] ; however, idiopathic oculomotor neuropathy is currently not reported in the veterinary literature. The aims of this study were to describe the clinical findings, magnetic resonance imaging (MRI) features, management, outcome, and long-term follow-up of canine cases diagnosed with idiopathic oculomotor neuropathy.
Methods
Medical records of all dogs referred to the Animal Health Trust for ophthalmoplegia/ophthalmoparesis from January 1999 to December 2014 were reviewed. Inclusion criteria included all cases with ophthalmoplegia/ophthalmoparesis (internal, external or both) as sole neuroophthalmologic sign, complete ophthalmic and neurologic examination, head MRI, and a minimum follow-up of one year. Dogs with progressive neurological signs not related to oculomotor neuropathy were excluded.
Patient information collected included the following: age, gender, breed, duration of clinical signs prior to referral, Vet Radiol Ultrasound, Vol. 58, No. 3, 2017, pp 334-343. clinical signs and affected side at presentation, MRI findings, cerebrospinal fluid (CSF) analysis, treatment, and follow-up. All MRI studies were reviewed by a boardcertified veterinary neurologist (E.B.) and a board-certified veterinary radiologist (R.D.), who were unaware of the side of the clinical signs. Disagreement was resolved by a consensus reading by the two reviewers. Five MRI parameters were evaluated in each case and included the following: (1) enlargement of CN III (equivocal, mild, or marked), (2) intensity at the area of CN III on T2W and T1W and also on fluid attenuation inversion recovery (FLAIR) when available (hypointense, isointense, or hyperintense), (3) postcontrast enhancement at the area of CN III (none, mild, or marked), (4) features of postcontrast enhancement at the area of CN III (focal or diffuse enhancement and homogenous or heterogeneous enhancement), and (5) anatomical region of the lesion. The enlargement was classified as equivocal when there was uncertainty about the presence or absence of enlargement, mild when the affected CN III was enlarged compared to the contralateral but there was no mass effect to the surrounding neuropil, and marked when the affected CN III was enlarged and there was mass effect to the surrounding neuropil. The intensity of CN III on T2W was classified as hypointense when its brightness was inferior to the brightness of normal gray matter, isointense when its brightness was equal to the normal gray matter, and hyperintense when its brightness was superior to the brightness of normal gray matter. This was repeated for T1W and also for FLAIR when available. The postcontrast enhancement was categorized as mild when there was contrast enhancement that was hypointense compared to the fat tissue on T1W images, and marked when the contrast enhancement was isointense to the fat tissue on T1W images. The contrast enhancement was classified as diffuse when detected throughout the length of CN III and focal when only present at a focal location of CN III. And finally, the contrast enhancement was categorized as homogenous when there was uniform enhancement and heterogeneous when it was dissimilar throughout the enhanced area. If follow-up MRI was available, the images were evaluated following the same parameters.
For each patient, long-term follow-up was performed with a combination of clinical reexaminations, evaluation of the clinical records postdiagnosis, and phone conversation with the owner. The referring veterinarians were contacted for the clinical history postdiagnosis of the patients. The owners whose dogs were alive at the start of the study were invited for a reexamination at the Animal Health Trust. Cases reexamined received a complete ophthalmic examination by a European College of Veterinary Ophthalmologists trained ophthalmologist (R.T.P.) and neurological examination by board-certified veterinary neurologists (C.F. and E.B.). In cases of dogs either lost to follow-up, dead or not available for reexamination, the long-term follow-up was determined based on the clinical records postdiagnosis and the phone conversation with the owner.
Results

Signalment and Clinical Findings
Fourteen cases met the inclusion criteria (Appendix 1). The mean (standard deviation, SD) and median (range) age at presentation were 6.25 years (2.3) years and 6.5 years (3-10 years), respectively. There were entire females (n = 1, 7%), neutered females (n = 7, 50%), entire males (n = 2, 14%), and neutered males (n = 4, 29%). The distribution of the individual breeds is shown in Appendix 1, with the more commonly affected breeds being Boxer (n = 4, 29%) and Border Collie (n = 2, 14%). The mean (SD) and median (range) duration of the clinical signs prior to referral were 73 days (195) and 5 days (1 day to 2 years), respectively. Cases presented with both internal and external ophthalmoplegia/ophthalmoparesis (n = 11, 79%, Fig 1. ) or only internal ophthalmoplegia (n = 3, 21%). The clinical signs were unilateral in all cases, being right sided (n = 8, 57%) or left sided (n = 6, 43%).
Magnetic Resonance Imaging Findings
Magnetic resonance of the head was performed using a 1.5 T scanner (GE Signa, GE Medical System, Milwaukee, WI). Noncontiguous transverse images with a 3-5 mm slice thickness and an interslice gap of 0.3-0.5 mm were generated with T1-weighted (T1W) and T2-weighted (T2W) spin echo pulse sequences in all three planes. Sequences included T1W and T2W and T1W with fat saturation (FAT-SAT). T1W FAT-SAT images were also acquired after intravenous paramagnetic contrast medium, 0.05 mmol/kg, gadobenate dimeglumine (Multi-Hance R , Bracco Imaging SpA, Milan Italy). T1W postcontrast FAT-SAT and fast FLAIR findings were recorded when available. Magnetic resonance findings are detailed in Appendix 2. Equivocal enlargement of CN III was noted in three cases (n = 3, 21%; Fig. 2 ), mild enlargement in five cases (n = 5, 35%; Fig. 3 ) and marked enlargement in six cases (n = 6, 43%; Fig. 4 ). The affected CN III was isointense on T2W and T1W precontrast sequences in five cases (n = 5, 35%; Fig. 2 ), hyperintense on T2W and isointense on T1W in seven cases (n = 7, 50%; Fig. 3 ), and hypointense on T2W and isointense on T1W in two cases (n = 2, 14%). FLAIR sequence was available in all cases but in two dogs; the intensity on FLAIR was equal to T2W in all cases but three cases, a case with hyperintense CN III on T2W and isointense on FLAIR, and two cases with isointense on T2W and hypointense on FLAIR, were noted. Contrast enhancement was present in all but two cases (n = 12, 86%), being marked in six cases (n = 6, 43%). When present, the contrast enhancement was focal in eight cases (n = 8, 67%) and diffuse in the rest (n = 4, 33%). In all cases, the anatomical region of the lesion was at the level of the middle cranial fossa; however, in some cases with diffuse enhancement, the lesion extended into the orbital fissure (n = 3, 21%). FIG. 3 . Transverse magnetic resonance images obtained at the level of the pituitary gland (asterisk) in a 7-year-old female neutered Boxer presented with internal ophthalmoplegia and external ophthalmoparesis of the left eye (case 7). There is mild enlargement of the left oculomotor nerve with hyperintensity on T2W (arrow; A), hyperintensity on FLAIR (arrow; B), and isointensity on T1W precontrast (arrow; C) with mild focal heterogeneous enhancement following contrast administration (arrow; D).
Other Findings
Comprehensive haematology and biochemistry were available in 13 cases and were unremarkable in all. Thyroid function was evaluated in three dogs and was determined within normal limits in all cases. One patient (case 7) had been previously diagnosed with hypothyroidism; however, the dog was receiving thyroid hormone supplementation and the thyroid values were within normal limits at presentation. Thoracic radiographs and abdominal ultrasonography were performed in seven patients and were unremarkable in all. Cerebrospinal fluid was collected from the cerebellomedullary cistern in 13 dogs (Appendix 1).
The mean (SD) and median (range) nucleated cell count was 1.99 cells/µL (2.06) and 1 cells/µL (0-8 cells/µL), respectively. The nucleated cell count was elevated in two patients (n = 2, 14%), with 6 and 8 cells/µL (reference range 0-5 cells/µL) respectively. The nucleated cellular population consisted of scattered small/medium lymphocytes and monocytes in all cases, apart from case 14 where the main population of cells was hypersegmented nondegenerated neutrophils. The mean (SD) and median (range) CSF total protein were 0.30 g/l (0.17) and 0.25 g/l (0.19-0.80 g/l), respectively. The total protein was elevated in one patient (n = 1, 7%; reference range 0-0.35 g/l; case 14). Polymerase chain reaction for canine distemper virus, FIG. 4 . Transverse magnetic resonance images obtained at the level of the pituitary gland (asterisk) in a 6-year-old male neutered Beagle presented with internal ophthalmoplegia and external ophthalmoparesis of the right eye (case 11). There is marked enlargement of the right oculomotor nerve with isointensity on T2W (arrow; A), hypointensity on FLAIR (arrow; B), and isointensity on T1W precontrast (arrow; C) with marked focal homogeneous enhancement following contrast administration (arrow; D).
Toxoplasma gondii and Neospora caninum were negative in blood and CSF in all dogs tested (n = 9, 64%).
Treatment and Follow-up
The treatment and follow-up information is detailed in Appendix 3. Anti-inflammatory to immunosuppressive doses of systemic corticosteroid (prednisolone at 1 mg/kg once to twice daily) was started at presentation in seven dogs (n = 7, 50%). Only two dogs showed improvement of the clinical signs while under systemic corticosteroid treatment (n = 2, 29%; cases 4 and 14). Case 10 developed severe gastrointestinal side effects within the first week of treatment and the medication was discontinued at that point. The neurological signs in this dog improved 3 weeks after the systemic corticosteroid treatment was discontinued. Case 9 showed improvement of the clinical signs 3 months after discontinuation of the systemic corticosteroid treatment. Furthermore, three dogs without systemic corticosteroid treatment (n = 3, 43%; cases 6, 7, and 12) improved 2 weeks to 4 months after their presentation. In the other seven dogs the clinical signs remained unchanged, three received a course of systemic steroid therapy and four had no treatment.
Six-month follow-up MRI scan was available in two cases (cases 8 and 14). In case 8, MRI findings at reexamination remained unchanged compared to presentation and clinical signs were not improved. In case 14, MRI at presentation revealed marked enlargement with marked diffuse postcontrast enhancement; however, at reexamination the followup MRI showed equivocal enlargement with no postcontrast enhancement (Fig. 5) , and clinical signs were improved at that time.
The mean (SD) and median (range) long-term followup time was 33.93 months (21.76) and 25 months (12-84 months), respectively. The external ophthalmoparesis improved in 64% cases (7/11 dogs) during this period of time and the neuromuscular strabismus resolved. The internal ophthalmoplegia/ophthalmoparesis remained unchanged in 79% cases (11/14 dogs) and partially resolved in 21% cases (3/14 dogs). The mean (SD) and median (range) time to improvement was 5.55 weeks (5.53) and 3.57 weeks (11 days to 4 months) respectively, from the day the clinical signs were first noted. Follow-up of over 1 year with complete ophthalmic and neurological reexamination by the authors was possible in six cases.
Discussion
This is the first descriptive study of idiopathic oculomotor neuropathy in dogs. The presumptive diagnosis of idiopathic neuropathy was made in all cases based on the failure on revealing an underlying cause. A putative association between cranial neuropathy and hypothyroidism has been stated in the veterinary literature, 18, 19 however, this is not borne out by other studies. 17, 20 None of the dogs of this study showed clinical signs of hypothyroidism and the thyroidal function was normal in the three dogs tested. One case had been previously diagnosed with hypothyroidism; however, the authors think that there is unlikely association between the hypothyroidism and the oculomotor neuropathy due to the fact that at the time of the onset of the clinical signs (oculomotor neuropathy) the dog did not reveal any clinical signs consistent with hypothyroidism and the thyroid function was controlled. Infectious causes of neuropathy are exceptionally rare in dogs, 2 and none of the dogs tested in this report for canine distemper virus, T. gondii and N. caninum were positive. In this study, the lack of clinical deterioration in all cases and the clinical improvement in several dogs might indicate the presence of an underlying oculomotor neuritis with subsequent permanent nerve damage. Furthermore, the MRI findings (CN III enlargement with contrast enhancement) and the mildly elevated cell count in CSF (in two dogs) could support this hypothesis. However, this hypothesis could not be confirmed due to the lack of histopathology and for this reason the term idiopathic neuropathy was adopted. Surgical biopsy at this area carries high operative morbidity due to the location and to the authors' knowledge this surgical approach has not been attempted in dogs.
All cases in this study presented with mydriasis, and only two dogs retained some pupillary response to light at presentation. On the other hand, external ophthalmoparesis was only seen in some dogs. The oculomotor parasympathetic axons are located superficially on the medial side of CN III, 1 subsequently if the neuropathy initiates in this location it is likely that only the parasympathetic component will be affected. The clinical signs were unilateral in all dogs in this study, similar to the reported canine cases of idiopathic facial neuropathy but different to trigeminal neuropathy. [13] [14] [15] [16] [17] There are several cases published of unilateral idiopathic trigeminal neuropathy in dogs, 21 however the majority are bilaterally affected. 13 Bilateral trigeminal neuropathy commonly presents with sudden inability to close the mouth 13 ; on the other hand, unilateral trigeminal neuropathy may only manifest with unilateral transitory masticatory muscle atrophy. 2 Subsequently, it is possible that unilateral cases of trigeminal neuropathy of the mandibular branch are overlooked by owners and veterinarians if the atrophy is mild or transitory. The mean recovery time of motor function was 5 weeks in the present study, similar to other idiopathic cranial neuropathies 13, 14, 16 ; however, a third of the cases affected with CN III motor dysfunction (4/11 dogs) in our study showed no signs of improvement. This finding differs from trigeminal neuropathy where the motor function recovered in all cases 13 ; but similar to facial neuropathy, where resolution of clinical signs was only seen in half of the affected dogs.
14-16 Some degree of mydriasis persisted in all cases in our study; however, almost a quarter of patients recovered partial CN III parasympathetic function. Medical treatment with corticosteroids did not appear to alter the course of the disease in this study, even though the dose used and length of course varied. Further studies are required to prove the efficacy of corticosteroids for the treatment of idiopathic oculomotor neuropathy, however corticosteroid therapy does not appear to change the clinical outcome of other cranial neuropathies. 13, 22 A total of 22 cases of canine ophthalmoplegia/ ophthalmoparesis (internal, external, or both) are published in the veterinary literature. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Of these 22 cases, only three report isolated CN III deficits, 5, 8, 10 the rest of the reports describe dogs with multiple cranial nerve dysfunction as part of middle cranial fossa syndrome (also known as cavernous sinus syndrome) or other neurological signs. [3] [4] [5] [6] [7] 9, 11, 12 The middle cranial fossa is a paired depression of the basiphenoid bone, located between the rostral and caudal cranial fossa at the base of the skull. 1 Multiple cranial nerves travel through the middle cranial fossa including the oculomotor, trochlear, and abducens nerves, as well as the three branches of the trigeminal nerve. 1 These cranial nerves exit/enter the skull through the orbital fissure (oculomotor nerve, trochlear nerve, abducens nerve, and ophthalmic branch of the trigeminal nerve), round foramen (maxillary branch of the trigeminal nerve), or oval foramen (mandibular branch of the trigeminal nerve). 1 The middle cranial fossa syndrome is a well-recognized syndrome in dogs characterized by variable impairment of these nerves. 2 In the veterinary literature, this syndrome is usually referred to as cavernous sinus syndrome. 3, 4, 6, 7, 9, 10 However, this term should ideally be discarded, because these cranial nerves are not directly related to the cavernous sinus. 2 Twelve of 22 dogs published in the veterinary literature showed unilateral deficits, [3] [4] [5] [6] [7] [8] [10] [11] [12] two cases presented with unilateral signs and became bilateral within days, 4, 6 and six cases had bilateral deficits at presentation. 4, 5, 9 All cases were reported to be secondary to neoplasia at the level of the middle cranial fossa or orbital fissure. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Ten dogs were euthanized at presentation, [3] [4] [5] 7, 10, 12 and for the rest, the mean life expectancy after diagnosis was 7.1 months 3, 4, 6, [8] [9] [10] with the longest survival time of 18 months. 6 Clinical signs deteriorated over this period of time in all cases, precipitating euthanasia. 3, 4, 6, [8] [9] [10] For this reason, the inclusion criteria of the current study demanded a minimal follow-up time of 12 months and only dogs with no deterioration of the neurological signs were included.
Magnetic resonance is the diagnostic imaging modality of choice in veterinary medicine for diseases affecting cranial nerves. 23 Magnetic resonance provides superior resolution of the retrobulbar and intracranial CN III pathway compared to computed tomography. 23 In this study, MRI enabled an accurate and detailed morphological assessment of the lesions in all cases, only two dogs had equivocal enlargement of the CN III and no postcontrast enhancement on MRI. Localization and extension of the lesions were in accordance with the neuroanatomic localization is all cases, and 6 months follow-up MRI was possible in two. Based upon the location, shape, invasiveness, signal intensity, homogeneity, and enhancement properties of the lesion, MRI features can help the differentiation between neoplastic and inflammatory disorders in cranial nerves dysfunction. 21, 24, 25 Human patients that have cranial nerve enhancement following contrast medium administration, but do not have an associated mass are considered to have cranial neuritis or ganglionitis rather than neoplasia. 25 Similarly in veterinary medicine, dogs with trigeminal neuritis confirmed postmortem had diffuse enlargement of the nerve without a mass lesion. 21 In the present study, six cases had marked enlargement of the CN III with mass effect in the surrounding tissue; three of these had diffuse enhancement in most of the length of the CN III, and the other marked focal enlargement of the nerve that could be considered a neoplastic lesion based on previously published literature. The pathogenesis of the disease in this study remains currently obscure, however, no deterioration of the clinical sings, no involvement of other cranial nerves or general condition was noted in any the dogs with a follow-up time of 20 to 41 months, which would be expected with a neoplastic lesion over that length of time. Therefore, we could conclude that idiopathic oculomotor neuropathy is not indicative of a serious underlying disorder.
The main limitations of this study include the low number of cases, lack of pathologic confirmation, lack of standardized MRI protocols and heterogeneous nature of the study design. Results could be more definitively supported with a prospective multicenter study. Futures studies could also evaluate the sensitivity and specificity of MRI for detecting CN III abnormalities in dogs with idiopathic oculomotor neuropathy. Moreover, MRI features (including a more objective measurement for cranial nerve enlargement) could be evaluated as prognostic factors for regaining full CN III function. The lack of histopathology was unavoidable due to the nonfatal nature of this condition and the high morbidity that a surgical biopsy could carry due to the location of the lesion. The authors applied stringent inclusion criteria for sampled animals in the current study in order to maximize the likelihood of a true positive diagnosis as much as possible.
In conclusion, findings from the current study supported including idiopathic oculomotor neuropathy as a differential diagnosis for dogs presenting with unilateral ophthalmoplegia/ophthalmoparesis (internal, external, or both) with the absence of other neurological and ophthalmic signs, and with MRI lesions restricted to CN III. These cases can have a good prognosis as the clinical signs do not deteriorate or can even improve without treatment. Gh, Greyhound; GR, Golden Retriever; LR, Labrador Retriever; ME, male entire; MN, male neutered; RC, Rough Collie; SBT, Staffordshire Bull Terrier; We, Weimaraner; y, years. * In case 13, the mydriasis was noted a month prior to presentation and the neuromuscular strabismus 2 years before.
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